FedReady

Orlance, Inc

Orlance, Inc is a small business in Seattle, WA registered on SAM.gov to bid on federal contracts. It has won 10 small business R&D awards worth $14.9 million through the SBIR and STTR programs since 2018, according to SBIR.gov.

UEI
KH6YJYH55G53
CAGE code
7PN99
SAM.gov registration
Active
Open contracts in NAICS 541714Is this your business? Get matched free

Registration details

Legal business nameOrlance, Inc
Unique Entity ID (UEI)KH6YJYH55G53
CAGE code7PN99
LocationSeattle, WA
SAM.gov registrationActive through Feb 22, 2027
Business started2016
Primary NAICS code541714: Research and Development in Biotechnology (except Nanobiotechnology)
Websitewww.orlance.com

Certifications and business types

  • Women-owned (self-reported in SAM.gov)
  • Women-owned small business (self-reported in SAM.gov)

SBA certifications let a business compete for set-aside contracts. See set-aside contracts explained.

SBIR and STTR awards

Orlance, Inc has won 10 small business R&D awards worth $14.9 million through the SBIR and STTR programs since 2018, 4 of them Phase II and 1 STTR. Funded by NIH.

AwardedAgencyProjectAmount
Sep 11, 2025NIHSTTR Phase I Therapeutic nucleic acid vaccine for chronic hepatitis B in HIV/HBV co-infected individuals$300,000
Aug 8, 2024NIHSBIR Phase I Enhanced Seasonal Influenza Vaccine Targeting Variable and Conserved Antigens$300,000
May 3, 2024NIHSBIR Phase I Gene Gun-delivered RNA vaccines.$600,000
Sep 21, 2023NIHSBIR Phase I Next Generation Gene-Gun Delivered DNA and RNA Immunotherapeutic Vaccines for Melanoma.$400,000
Sep 1, 2023NIHSBIR Phase II Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine$3 million
May 3, 2022NIHSBIR Phase II Universal Influenza A/B Vaccine$3 million
Aug 7, 2020NIHSBIR Phase I Universal Influenza A/B Vaccine$300,000
Sep 1, 2019NIHSBIR Phase II Development of a rapid response nucleic acid vaccine strategy for coronavirusepidemics$4.9 million

Showing the newest 8. Award data from SBIR.gov. SBIR and STTR awards are grants or contracts for R&D, so some don't appear in its federal contract history.

Federal contract history

USAspending.gov shows no federal prime contracts for this UEI in the last five years. Its SBIR and STTR awards are listed above.

NAICS codes Orlance, Inc is small under

On its SAM.gov registration, Orlance, Inc meets the SBA size standard for these industries, so it can bid on small business set-asides that use them.

  • 541714 Research and Development in Biotechnology (except Nanobiotechnology)
  • 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Open contracts in Orlance, Inc's NAICS codes

313 open federal opportunities on SAM.gov use a NAICS code Orlance, Inc is small under. These are due soonest.

Get matches like these by email, free →

Similar small businesses

Other small businesses with the same primary NAICS code (541714) that have won federal contracts, starting with Washington:

Frequently asked questions

What is Orlance, Inc's CAGE code?

Orlance, Inc's CAGE code is 7PN99. The Defense Logistics Agency assigns CAGE codes when a business registers on SAM.gov.

What is Orlance, Inc's UEI?

Orlance, Inc's Unique Entity ID (UEI) is KH6YJYH55G53. SAM.gov assigns the UEI, and it identifies the business across the federal government.

Is Orlance, Inc's SAM.gov registration active?

Yes, as of the latest SAM.gov public data, Orlance, Inc's registration is active through Feb 22, 2027. Registrations are renewed every year.

Is Orlance, Inc a small business?

Orlance, Inc is registered on SAM.gov as small under 2 NAICS codes, including its primary code, 541714. Size is set per NAICS code, so a business can be small for some contracts and not others.

Keep going

Registration details come from SAM.gov's public entity extract and contract figures from USAspending.gov. Contact names and street addresses are left out. To change these details, update the registration on SAM.gov. To ask us to remove this page, email hello@fedready.us.